Nucleic acid constructs and cells, and methods utilizing...

Details Nucleic acid constructs and cells, and methods utilizing... Nucleic acid constructs and cells, and methods utilizing...

2007-11-13

2007-11-13

Falk, Anne-Marie (Department: 1632)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093200

Reexamination Certificate

active

09691889

ABSTRACT:
A method of modifying the electrophysiological function of an excitable tissue region of an individual is provided. The method includes the step of implanting cells into the excitable tissue region. Each implanted cell is (a) capable of forming gap junctions with at least one cell of the excitable tissue region; and (b) capable of forming a functional ion channel or transporter, wherein the functional ion channel or transporter is capable of modifying the electrophysiological function of the excitable tissue region.

REFERENCES:
patent: 5837220 (1998-11-01), Blake et al.
patent: 5955259 (1999-09-01), Holmes et al.
patent: 6013766 (2000-01-01), Elgoyhen et al.
patent: 6087488 (2000-07-01), Ganetzky et al.
patent: 6099832 (2000-08-01), Mickle et al.
patent: 6100046 (2000-08-01), Elgoyhen et al.
patent: 6110459 (2000-08-01), Mickle et al.
patent: 2004/0266717 (2004-12-01), Donahue et al.
patent: WO00/63434 (2000-10-01), None
patent: WO02/087419 (2002-11-01), None
Crystal et al. Transfer of genes to humans: early lessons and obstacles to success pp. 404-410 1995.
Deonarain Ligand-targeted receptor-mediated vectors for gene delivery pp. 53-69 1998.
Friedmann Overcoming the Obstacles pp. 96-101 1997.
Jackowski Neural injury repair: hope for the future as barriers to effective CNS regeneration become clearer pp. 303-317 1995.
DeSilva Gene therapy's growing pains pp. 1050-1055 1995.
Miller et al. Targeted vectors for gene therapy pp. 190-199 1995.
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy pp. 1-40 2002.
Verma et al. Gene therapy-promises, problems and prospects pp. 239-242 1997.
Koh et al. (1995) Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J. Clin. Invest. 96: 2034-2042.
Hoppe et al. (1999) Manipulation of cellular excitability by cell fusion: Effects of rapid introduction of transient outward K+ current on the guinea pig action potential. Circulation Research 84: 964-672.
Donahue et al. (2005) Gene therapy for cardiac arrhythmias. Trends Cardiovasc. Med. 15(6): 219-224.
Donahue et al. (2005) Modification of cellular communication by gene transfer. Ann. N.Y. Acad. Sci. 1047: 157-165.
Meir et al. (1999) Ion channels in presynaptic nerve terminals and control of transmitter release. Physiological Reviews 79(3): 1019-1080.
Rubanyi et al. (2001) The future of human gene therapy. Molecular Aspects of Medicine 22: 113-142.
Tomaselli et al. (2003) Somatic gene transfer and cardiac arrhythmias: Problems and prospects. J. Cardiovasc. Electrophysiol. 14: 547-550.
Feld et al. “Electrophysiological Modulation of Cardiomyocytic Tissue by Transfected Fibroblasts Expressing Potassium Channels: A Novel Strategy to Manipulate Excitability”, Circulation 105(4): 522-9, 2002.
Hammond et al. “Angiogenic Gene Therapy for Heart Disease: A Review of Animal Studies and Clinical Trials”, Cardiovasc Res 49(3): 561-7, 2001.
DeGroot et al. “Clinical Review 131: Gene Therapy for Thyroid Cancer: Where Do We Stand?”, J Clin Endocrinol Metab 86(7): 2923-8, 2001.
Siegel “Biotechnology and Clinical Trials”, J Infect Dis 185(Suppl 1): S52-7, 2002.
Reinlib et al. “Cell Transplantation as Future Therapy for Cardiovascular Disease?: A Workshop of the National Heart, Lung, and Blood Institute”, Circulation 101(18): E182-7, 2000.
Roth et al. “Nonviral Transfer of the Gene Encoding Coagulation Factor VIII in Patients With Severe Hemophilia A”, N Engl J Med 344(23): 1735-42, 2001.
Fast et al, “Anisotropic conduction in monolayers of neonatal rat heart cells cultured on collagen substrate”, Circ Res. Sep. 1994;75(3):591-5.
Marshall “Gene Therapy's Growing Pains”, Science 269: 1050-1055, 1995.
Verma et al. “Gene Therapy—Promises, Problems and Prospects”, Nature 389(6648): 239-42, 1997.
Johns et al, “Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability”, J Clin Invest. Aug. 1995;96(2):1152-8.
Nuss et al, “Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes”, J Clin Invest. Mar. 1999;103(6):889-96.
Donahue et al, “Focal modification of electrical conduction in the heart by viral gene transfer”, Nat Med. Dec. 2000;6(12):1395-8.
Miller et al. “Targeted Vectors for Gene Therapy”, FASEB J. 9(2): 190-9, 1995.
Orkin et al. “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”: 1-40 1995, + http://.nih.gov
ews/panelrep.html (1975).
Soonpaa et al. “Formation of Nascent Intercalated Disks Between Grafted Fetal Cardiomyocytes and Hot Myocardium”, Science 264(5155): 98-101, 1994.
Rook et al, “Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs”, Am J Physiol. Nov. 1992;263(5 Pt 1):C959-77.
Gussoni et al. “Normal Dystrophin Transcripts Detected in Duchenne Muscular Dystrophy Patients After Myoblast Transplantation”, Nature 356(6368): 435-8, 1992.
Freed et al. “Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months After Transplantation for Parkinson's Disease”, N Engl J Med 327(22): 1549-55, 1992.
Jockusch et al. “Long-Term Expression of Isomyosins and Myoendocrine Functions in Ectopic Grafts of Atrial Tissue”, Proc Natl Acad Sci USA 83(19): 7325-9, 1986.
Bader et al. “Repair and Reorganization of Minced Cardiac Muscle in the Adult Newt (Notophthalmus Viridescens)”, J Morphol 155(3): 349-57, 1978.
Lerche et al. “Ion Channels and Epilepsy”, Am J Med Genet 106(2): 146-59, 2001.
Luo et al. “A Model of the Ventricular Cardiac Action Potential, Depolarization, Repolarization,and Their Interaction”, Circ Res 68(6): 1501-26, 1991.
Marom et al. “Modeling State-Dependent Inactivation of Membrane Currents”, Biophys J. 67(2): 515-20, 1994.
Marom “Slow Changes in the Availability of Voltage-Gated Ion Channels: Effects on the Dynamics of Excitable Membranes”, J Membr Biol 161(2): 105-13, 1998.
Marom et al. “State-Dependent Inactivation of the Kν3 Potassium Channel”, Biophysical Journal 67:579-589, 1994.
Crystal “Transfer of Genese to Humans: Early Lessons and Obstacles to Success”, Science 270: 404-410, 1995.
Deonarain “Ligand-Targeted Receptor-Mediated Vectors for Gene Delivery”, Exp. Opin. Ther. Patents 8(1): 53-69, 1988.
Friedmann “Overcoming the Obstacles to Gene Therapy”, Sci Am 276(6): 96-101, 1997.
Jackowski “Neural Injury Repair: Hope for the Future as Barriers to Effective CNS Regeneration Become Clearer”, British Journa of Neurosurgery 9(3): 303-17, 1995.
Sangro et al. “Gene Therapy of Neoplastic LiverDiseases”, International Journal of Cell Biology, 35(2): 135-148, 2003. Abstract.
Bruckner “INGN-201. Introgen Therapeutics”, Current Opinion Invetigating Drugs, 2(12): 1776-1785, 2001. Abstract.
Nasz et al. “Recombinant Adenovirus Vectors for Gene Therapy and Clinical Trials”, Acta Microbiol.Immunol. Hung, 48(3-4): 323-348, 2001. Abstract.
Cohen et al. “ONYX-015-Onyx Pharmaceuticals”, Current Opinion Investigating Drugs, 2(12): 1770-1775, 2001. Abstract.
Kirn “Oncolytic Virotherapy for Cancer with Adenovirus D11520 (Onyx-015): Results of Phase I and II Trials”, Expert Opinion Biol. Ther., 1(3): 525-538, 2001. Abstract.
Merritt et al. “Clinical Evaluation of Adenoviral-Mediated P53 Gene Transfer: Review of INGN 201 Studies”, Semin. Oncol., 28)Suppl. 16): 105-114, 2001. Abstract.
Banerjee “Genasense (Genta Inc)” Current Opinion Investig. Drugs, 2(4):574-580, 2001. Abstract.
Ebihara et al. “Co-Expression of Lens Fiber Connexins Modifies Hemi-G

Affiliated with

Also associated with

Rating

Nucleic acid constructs and cells, and methods utilizing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid constructs and cells, and methods utilizing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid constructs and cells, and methods utilizing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3847151